Global Wound Care Biologics Market– Industry Trends and Forecast to 2025

Market Analysis: Global Wound Care Biologics Market

The Global Wound Care Biologics Market is expected to reach USD 2.78 billion by 2025, from USD 1.29 billion in 2017 growing at a CAGR of 10.09% during the forecast period of 2018 to 2025. The upcoming market report contains data for historic years 2014 & 2015, the base year of calculation is 2016 and the forecast period is 2018 to 2025.

Market Definition: Global Wound Care Biologics Market

The other name of Biologics is biopharmaceuticals which are extracted from biological sources. They are found in the form of medical, biological, any pharmaceutical drug product. Hence the use of biologicals has increased significantly in past years; these are used in treating the wounds primarily. Several devices are currently enhancing the natural repair mechanisms; however the quest for tissue regeneration is becoming clearer. As a matter of fact there is no single biologic that can provide all the needed components for dermal regeneration. These treatments related to the wound care biologics help in the refurbishment of the inborn repair mechanisms and may involve the application of active biological agents, for example plant-derived active biomolecules which exhibit antioxidant, antimicrobial, or anti-inflammatory attributes. Substances that are prepared via a living are used in the prevention, diagnosis, or treatment of cancer and other diseases are called as biologics. Biological drugs include antibodies, interleukins, and vaccines.

There are skin substitutes in wound care biologics which can be classified as temporary or permanent and synthetic or biological some of them are temporary skin substitutes, permanent skin substitutes, biological skin substitutes, xenograft, skin allograft, amnion, cultured epithelial autografts and synthetic skin substitutes. Biosynthesis is also called anabolism, there are biosynthetic products.

Major Market Drivers and Restraints:

Rising incidences of burn injuries
Rapid growth in the geriatric population
Growing incidence of ulcers and target conditions
Innovation in wound care biologics
Awareness programs for wound care treatment and management
High cost of wound treatment and wound care biologics
Risk of skin substitute failure

Market Segmentation: Global Wound Care Biologics Market

The global wound care biologics market is segmented based on product type, end user, application, distribution channel and geographical segments.
Based on product, the global wound care biologics market is segmented into biologic skin substitutes and topical agents. The sutures market segment is further segmented into human donor tissue-derived products, acellular animal-derived products and biosynthetic products.
On the basis of wound type, the global wound care biologics market is classified into ulcers, surgical and traumatic wounds, and burns. The ulcers market is further sub-segmented into venous ulcers, diabetic foot ulcers, pressure ulcers and other ulcers
On the basis of end users the market is segmented into Hospitals, ASCs, Burn Centers and Wound Clinics.
Based on geography the global wound care biologics market report covers data points for 28 countries across multiple geographies namely North America & South America, Europe, Asia-Pacific and, Middle East & Africa. Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa and, Brazil among others.

Competitive Analysis: Global Wound Care Biologics Market

The global wound care biologics market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of wound care biologics market for global, Europe, North America, Asia Pacific and South America.

Major Market Competitors/Players: Global Wound Care Biologics Market

Some of the major players operating in the global wound care biologics market are Smith & Nephew , Mölnlycke Health Care AB (Investor AB) , Integra Lifesciences , Wright Medical , Mimedx Group , Vericel , Anika Therapeutics , Osiris Therapeutics , Organogenesis , Kerecis ,Solsys Medical and Acell , Marine Polymer Technologies among others.

Research Methodology: Global Wound Care Biologics Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. 

Primary Respondents

Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.

Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, Regulatory Affairs Managers among others

Global Wound Care Biologics Market– Industry Trends and Forecast to 2025

.